ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO404

Predictors of New-Onset Atrial Fibrillation in Patients with ESKD: A Multicenter, Retrospective, Observational Cohort Study

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Mina, Jonathan, Staten Island University Hospital, Staten Island, New York, United States
  • Haddadin, Fadi, Staten Island University Hospital, Staten Island, New York, United States
  • Almardini, Shaza, Staten Island University Hospital, Staten Island, New York, United States
  • El Gharib, Khalil, Staten Island University Hospital, Staten Island, New York, United States
  • El Sayegh, Suzanne E., Staten Island University Hospital, Staten Island, New York, United States

Group or Team Name

  • Staten Island Team.
Background

According to the CDC, A.Fib is the most prevalent heart arrhythmia, cited in 183,321 US deaths in 2019, with 26,535 directly attributed. ESRD is a leading cause of US mortality, impacting 37 million adults. Previous studies link CKD with increased A.fib risk, possibly due to shared risk factors. Our study examines predictive factors for new onset A.fib in ESRD patients at Northwell Health System.

Methods

6,814 cases of ESRD patients were identified from February 2018 to December 2020. Patients with a prior history of A.Fib were excluded. Patients with missing or extreme BMI data and missing tobacco use data were excluded. Sample size was 5,326. 1,564 diagnosed with ESRD experienced new-onset A.Fib (cases) while 3,762 had no history of A.Fib (controls). Predictors studied were CAD, BMI, Sex, Race, Ethnicity, HTN, Diabetes (DM), and Smoking Status.

Results

Out of the 5,326 ESRD patients, 1,564 (29.4%) were cases, and 3,762 (70.6%) were controls. Increasing age (OR 1.038/yr, p<0.0001), obesity (OR 1.225, p=0.0135), and CAD (OR 1.682, 95%, p<0.0001) were linked to higher odds of A.Fib. African American and other racial patients had decreased odds compared to Whites (OR 0.581 and OR 0.772, respectively). HTN, sex, DM, and smoking did not significantly associate with A.Fib risk.

Conclusion

Age, obesity, and CAD were risk factors for new onset Afib in ESRD, while African American and other racial patients had lower odds compared to Whites. HTN, sex, DM, and smoking showed no significant associations. Further research should delve into underlying mechanisms, explore interventions for A.Fib risk in vulnerable populations, and assess demographic factors' impact on outcomes.